Sotera Health (SHC) Set to Announce Quarterly Earnings on Thursday

Sotera Health (NYSE:SHCGet Rating) is scheduled to post its quarterly earnings results before the market opens on Thursday, May 5th. Analysts expect Sotera Health to post earnings of $0.18 per share for the quarter. Sotera Health has set its FY22 guidance at $0.93-0.99 EPS and its FY 2022 guidance at $0.930-$0.990 EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.

Sotera Health (NYSE:SHCGet Rating) last released its quarterly earnings data on Tuesday, March 1st. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. Sotera Health had a return on equity of 42.00% and a net margin of 12.55%. The business had revenue of $241.25 million for the quarter, compared to analysts’ expectations of $238.90 million. During the same period in the previous year, the business posted $0.07 earnings per share. Sotera Health’s quarterly revenue was up 11.3% on a year-over-year basis. On average, analysts expect Sotera Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Shares of NYSE:SHC opened at $20.77 on Thursday. The business’s fifty day moving average price is $21.12 and its two-hundred day moving average price is $22.32. Sotera Health has a fifty-two week low of $18.31 and a fifty-two week high of $27.38. The stock has a market capitalization of $5.87 billion, a price-to-earnings ratio of 49.45 and a beta of 0.32. The company has a debt-to-equity ratio of 3.04, a current ratio of 2.15 and a quick ratio of 1.81.

A number of analysts have weighed in on SHC shares. Barclays cut Sotera Health from an “overweight” rating to an “equal weight” rating and set a $24.00 price target on the stock. in a research report on Wednesday, March 2nd. The Goldman Sachs Group reduced their price objective on Sotera Health from $31.00 to $27.00 and set a “buy” rating on the stock in a research note on Monday, March 21st. Jefferies Financial Group lowered Sotera Health from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $34.00 to $22.00 in a research note on Thursday, March 3rd. Wolfe Research began coverage on Sotera Health in a research note on Tuesday, April 5th. They issued an “outperform” rating and a $26.00 price objective on the stock. Finally, KeyCorp cut their price target on Sotera Health from $33.00 to $30.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 2nd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $26.57.

A number of large investors have recently added to or reduced their stakes in the business. Marshall Wace LLP bought a new stake in shares of Sotera Health in the fourth quarter worth about $216,000. Amalgamated Bank grew its holdings in shares of Sotera Health by 17.1% during the fourth quarter. Amalgamated Bank now owns 21,018 shares of the company’s stock worth $495,000 after buying an additional 3,062 shares in the last quarter. UBS Group AG grew its holdings in shares of Sotera Health by 461.7% during the third quarter. UBS Group AG now owns 19,259 shares of the company’s stock worth $504,000 after buying an additional 15,830 shares in the last quarter. Sei Investments Co. grew its holdings in shares of Sotera Health by 64.9% during the fourth quarter. Sei Investments Co. now owns 27,842 shares of the company’s stock worth $656,000 after buying an additional 10,954 shares in the last quarter. Finally, Susquehanna International Group LLP grew its holdings in shares of Sotera Health by 294.6% during the fourth quarter. Susquehanna International Group LLP now owns 36,663 shares of the company’s stock worth $863,000 after buying an additional 27,372 shares in the last quarter. 87.13% of the stock is currently owned by hedge funds and other institutional investors.

Sotera Health Company Profile (Get Rating)

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.

Further Reading

Earnings History for Sotera Health (NYSE:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.